Home › NDC Lookup › Drug shortages › Phenoxybenzamine Hydrochloride Capsule

Phenoxybenzamine Hydrochloride Capsule shortage

Phenoxybenzamine Hydrochloride Capsule is currently listed in shortage by the FDA. The FDA lists 3 affected products. This page was last refreshed from FDA data on Oct 5, 2026.

To Be Discontinued ⚠ Supply risk: High Cardiovascular 3 products 308 days First posted Dec 1, 2025 Updated Dec 1, 2025
Here’s the bottom line

Advanz Pharma is permanently stopping production of phenoxybenzamine hydrochloride 10 mg capsules. Other makers — including Burel Pharmaceuticals, Amneal Pharmaceuticals, and Novitium Pharma — have not reported a shortage and still list this medicine as available.

Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).

Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →
3
Affected NDCs
1
Reporting manufacturers
0/1
Reporting mfrs supplying
0/1
Affected strengths supplied
308
Days in shortage
Source: FDA Drug Shortages Database API (openFDA). Last refreshed Oct 5, 2026 · today

What’s in shortage — at a glance

These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Phenoxybenzamine Hydrochloride Capsule. Other makers that haven’t reported a problem are shown in the green card below.

Availability of affected NDCs
From the FDA shortage report
3 NDCs
To be discontinued 3
Affected strengths still supplied
Among manufacturers reporting this shortage
0/1 strengths
No supply 1
FDA-reporting manufacturers with supply
Among manufacturers reporting this shortage
0/1 makers
No supply 1
✓ Other manufacturers not reporting a shortage
Still-marketed Phenoxybenzamine Hydrochloride Capsule from companies that have not filed an FDA shortage — these are not counted in the figures above. Stock can still vary by pharmacy.
Burel Pharmaceuticals, LLC Amneal Pharmaceuticals NY LLC Novitium Pharma LLC
See all other options & details →
Shortage timeline
  1. Dec 1, 2025
    Currently in shortage
    3 of 3 products affected.
  2. Dec 1, 2025
    First reported to the FDA
    3 products first listed.

Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.

What exactly is on backorder — by manufacturer

Manufacturer: Advanz Pharma (US) Corp. 📞 847-283-7921 3 NDCS click to expand
Status NDC / product Strength Availability Related information Reason
To Be Discontinued Dibenzyline, Capsule, 10 mg (NDC 66993-066-02) NDC 66993-0066-02 — — Discontinuation of the manufacture of the drug —
To Be Discontinued Dibenzyline, Capsule, 10 mg (NDC 59212-001-01) NDC 59212-0001-01 — — Discontinuation of the manufacture of the drug —
To Be Discontinued Dibenzyline, Capsule, 10 mg (NDC 59212-001-02) NDC 59212-0001-02 — — Discontinuation of the manufacture of the drug —

These rows are manufacturer reports to the FDA for Phenoxybenzamine Hydrochloride Capsule — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Phenoxybenzamine Hydrochloride Capsule? options further down this page.

Why is Phenoxybenzamine Hydrochloride Capsule in shortage?

Advanz Pharma has reported to the FDA that it is permanently stopping the manufacturing of Dibenzyline (phenoxybenzamine hydrochloride) 10 mg capsules. This affects all of their package sizes of this product. They did not share a specific public reason for why they made this decision — just that manufacturing is being discontinued.

It's worth knowing that this report reflects only what Advanz Pharma has filed with the FDA. It does not mean this medication is disappearing from every source — other manufacturers may still produce it and would be listed separately.

Based on the manufacturer-reported reason(s) and notes on file with the FDA for Phenoxybenzamine Hydrochloride Capsule, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.

What should I do if I take Phenoxybenzamine Hydrochloride Capsule?

Phenoxybenzamine hydrochloride 10 mg capsules are currently on the FDA shortage list. I want to walk you through what this means so you can plan your next refill with confidence.

The affected strength is the 10 mg capsule, which is the only strength involved. The manufacturer that filed this report, Advanz Pharma (maker of the brand Dibenzyline), lists this strength as being discontinued, so right now there is no reported supply from that company. Because this is a discontinuation rather than a temporary delay, the supply problem from this particular maker may be permanent — which makes a conversation with your prescriber or pharmacist the right next step.

Importantly, this report reflects only one manufacturer. The same medicine, phenoxybenzamine 10 mg capsules, is also listed as available from other makers — including Burel Pharmaceuticals, Amneal, and Novitium — so your pharmacy may still be able to source it, though it may not be in local stock.

Here is what I suggest:

  • Do not stop, skip, or change your dose on your own. Keep taking it as prescribed.
  • Ask your pharmacy to check wholesalers and these other manufacturers for the 10 mg capsule.
  • If it cannot be found, ask your prescriber or pharmacist about a clinician-chosen option.

Manufacturer contact numbers are listed on this page for reference; pharmacies usually handle those calls.

See “Where else can I get Phenoxybenzamine Hydrochloride Capsule?” below ↓ The same medicine from manufacturers not reporting a shortage, alternative dosage forms, and therapeutic equivalents with pricing.
If you are a patient:
  • Don’t stop or change the medication on your own — talk to your prescriber first.
  • If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
  • Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
  • Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Keep reading
Our full Phenoxybenzamine guide

Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.

Read the Phenoxybenzamine guide →

Where else can I get Phenoxybenzamine Hydrochloride Capsule?

FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Phenoxybenzamine Hydrochloride Capsule is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.

Same medicine, other manufacturers (not reported short)

Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:

ProductStrengthForm / routeManufacturerNDC
Phenoxybenzamine Hydrochloride PHENOXYBENZAMINE HYDROCHLORIDE 10 mg/1 Capsule · Oral Burel Pharmaceuticals, LLC 35573-0473-02
Phenoxybenzamine Hydrochloride PHENOXYBENZAMINE HYDROCHLORIDE 10 mg/1 Capsule · Oral Amneal Pharmaceuticals NY LLC 60219-1502-01
Phenoxybenzamine Hydrochloride PHENOXYBENZAMINE HYDROCHLORIDE 10 mg/1 Capsule · Oral Novitium Pharma LLC 70954-0365-10
Therapeutic equivalents & pricing 8 productsclick to expand

Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.

ProductManufacturerPackageNADAC $/unitAB ratingAvailability
Phenoxybenzamine Hydrochloride 10 mgNDC 35573-0473-02 Burel 100 capsules — AB FDA listed
Phenoxybenzamine Hydrochloride 10 mgNDC 59651-0327-01 Aurobindo 100 capsules — — FDA listed
Phenoxybenzamine hydrochloride 10 mgNDC 60219-1502-01 Amneal 100 capsules — AB FDA listed
Phenoxybenzamine Hydrochloride 10 mgNDC 70954-0365-10 Novitium 100 capsules — AB FDA listed
Phenoxybenzamine Hydrochloride 10 mgNDC 72603-0229-01 NorthStar 100 capsules — AB Discontinued
Phenoxybenzamine Hydrochloride 10 mgNDC 66993-0066-02 Prasco 100 capsules — — Discontinued
Dibenzyline 10 mgNDC 59212-0001-01 Concordia 100 capsules — — Discontinued
Dibenzyline 10 mgNDC 59212-0001-02 Concordia 100 capsules — — Discontinued

Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.

Other drugs in the same treatment class

These are different medicines — not other versions of Phenoxybenzamine Hydrochloride Capsule — that fall in the same broad treatment class (alpha-adrenergic blocking agents) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.

Identity & classification

GCN Seq No 005108
GCN 20540
HICL code 002098
Ingredient (HICL) Phenoxybenzamine Hcl
HIC1 code J
Therapeutic class — broad (HIC1) Autonomic Nervous System
HIC2 code J7
Therapeutic class — intermediate (HIC2) Antiadrenergics
HIC3 code J7B
Therapeutic class — specific (HIC3) Alpha-Adrenergic Blocking Agents
AHFS code 12:16.04.04
AHFS class Non-Sel.alpha-Adrenergic Blocking Agents
FDB label name PHENOXYBENZAMINE HCL 10 MG CAP
FDB brand name Phenoxybenzamine Hcl
Legend status F — Federal legend — prescription drug or device
Where does this data come from?
Identity codes come from First Databank (FDB) (HICL ingredient, HIC1–3 therapeutic-class hierarchy, GCN, AHFS class, legend status) and Medi-Span GPI, mapped from a representative affected NDC. Licensed reference data — for identification only.

Other cardiovascular shortages

Phenoxybenzamine Hydrochloride Capsule shortage FAQs

Is Phenoxybenzamine Hydrochloride Capsule in shortage?
Yes — the FDA currently lists Phenoxybenzamine Hydrochloride Capsule in shortage (status: “To Be Discontinued”, first reported Dec 1, 2025). 3 of 3 products are affected. This is national, manufacturer-reported data, so your pharmacy may still have stock.
Which products are affected?
Dibenzyline, Capsule, 10 mg (NDC 66993-066-02) (NDC 66993-0066-02); Dibenzyline, Capsule, 10 mg (NDC 59212-001-01) (NDC 59212-0001-01); Dibenzyline, Capsule, 10 mg (NDC 59212-001-02) (NDC 59212-0001-02). The full per-NDC list (availability, manufacturer and status) is in the table above — each NDC links to its own page.
When will Phenoxybenzamine Hydrochloride Capsule be available again?
The FDA does not publish a guaranteed restock date, and no estimated-recovery note is on file. Availability can change daily — confirm with your pharmacy.
Can I still get Phenoxybenzamine Hydrochloride somewhere?
Other manufacturers (Burel Pharmaceuticals, LLC, Amneal Pharmaceuticals NY LLC, Novitium Pharma LLC) still market it and have not reported a shortage. See “Where else can I get Phenoxybenzamine Hydrochloride Capsule?” above — stock still varies by pharmacy.
What should I do if I take Phenoxybenzamine Hydrochloride Capsule?
Don’t stop or change it on your own. Ask your pharmacist whether they can order it from another manufacturer or a different strength/package size, and ask your prescriber about a long-term plan before your supply runs out.

Still have a question about the Phenoxybenzamine Hydrochloride Capsule shortage?

Ask a pharmacist about this shortage →
How to read the Supply-Risk rating
Low (1–2)Multiple manufacturers still supplying and most strengths or pack sizes sourceable.
Medium (3)Some constraint — fewer suppliers or a notable share of NDCs unavailable.
High (4–5)Down to a single source, most strengths or pack sizes unsourceable, or a long-running outage.
Where does this data come from?
Shortage records come from the FDA Drug Shortages Database API via openFDA (/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.
Data structure & sourcing designed and verified by Dr. Brian Staiger, PharmD.
← Back to all current drug shortages